Evaluation of erectile dysfunction and associated cardiovascular risk using structured questionnaires in Chinese type 2 diabetic men

International Journal of Andrology

Volumn 33, Issue 6, 2010, Pages 853-860

  Yu, L W ^a   Kong, A P ^a   Tong, P C ^a   Tam, C ^a   Ko, G T ^a   Ho, C ^a   So, W ^a   Ma, R C ^a   Chow, C ^a   Chan, J C ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Diabetes; Erectile dysfunction; Risk assessment

Indexed keywords

ALBUMIN; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INSULIN; THIAZIDE DIURETIC AGENT;

ADULT; AGE DISTRIBUTION; AGED; ALBUMINURIA; ARTICLE; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CHINESE; CREATININE URINE LEVEL; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DISEASE SEVERITY; ERECTILE DYSFUNCTION; HUMAN; HYPERTENSION; HYPOGONADISM; INSULIN TREATMENT; INTERNATIONAL INDEX OF ERECTILE FUNCTION QUESTIONNAIRE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; QUESTIONNAIRE; STRUCTURED QUESTIONNAIRE;

ADULT; AGED; ALBUMINURIA; ASIAN CONTINENTAL ANCESTRY GROUP; CARDIOVASCULAR DISEASES; CHINA; CORONARY DISEASE; CREATININE; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; ERECTILE DYSFUNCTION; HONG KONG; HUMANS; INSULIN; LOGISTIC MODELS; MALE; MIDDLE AGED; PREVALENCE; QUESTIONNAIRES; RISK FACTORS;

EID: 78650437217     PISSN: 01056263     EISSN: 13652605     Source Type: Journal    
DOI: 10.1111/j.1365-2605.2009.01026.x     Document Type: Article

References (44)

1. Barrett-Connor, E. (2004) Cardiovascular risk stratification and cardiovascular risk factors associated with erectile dysfunction: assessing cardiovascular risk in men with erectile dysfunction. Clinical Cardiology 27, I8-I13.
2. Barrett-Connor, E. (2005) Heart disease risk factors predict erectile dysfunction 25 years later (the Rancho Bernardo study). American Journal of Cardiology 96, 3M-7M.
3. Chiurlia, E., D'Amico, R., Ratti, C., Granata, A. R., Romagnoli, R. & Modena, M. G. (2005) Subclinical coronary artery atherosclerosis in patients with erectile dysfunction. Journal of the American College of Cardiology 46, 1503-1506.
4. Cho, N. H., Ahn, C. W., Park, J. Y., Ahn, T. Y., Lee, H. W., Park, T. S. et al. (2006) Prevalence of erectile dysfunction in Korean men with type 2 diabetes mellitus. Diabetic Medicine 23, 198-203.
5. De Berardis, G., Franciosi, M., Belfiglio, M., Di Nardo, B., Greenfield, S., Kaplan, S. H. et al. (2002) Erectile dysfunction and quality of life in type 2 diabetic patients: a serious problem too often overlooked. Diabetes Care 25, 284-291.
6. Deckert, T., Feldt-Rasmussen, B., Borch-Johnsen, K., Jensen, T. & Kofoed-Enevoldsen, A. (1989) Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia 32, 219-226.
7. Deutsch, S. & Sherman, L. (1980) Previously unrecognized diabetes mellitus in sexually impotent men. JAMA 244, 2430-2432.
8. El-Sakka, A. I., Morsy, A. M., Fagih, B. I. & Nassar, A. H. (2004) Coronary artery risk factors in patients with erectile dysfunction. Journal of Urology 172, 251-254.
9. Fedele, D., Coscelli, C., Santeusanio, F., Bortolotti, A., Chatenoud, L., Colli, E., Landoni, M. & Parazzini, F. (1998) Erectile dysfunction in diabetic subjects in Italy. Gruppo italiano studio deficit erettile nei diabetici. Diabetes Care 21, 1973-1977.
10. Feldman, H. A., Goldstein, I., Hatzichristou, D. G., Krane, R. J. & McKinlay, J. B. (1994) Impotence and its medical and psychosocial correlates: results of the Massachusetts male aging study. Journal of Urology 151, 54-61.
11. Ganz, P. (2005) Erectile dysfunction: pathophysiologic mechanisms pointing to underlying cardiovascular disease. American Journal of Cardiology 96, 8M-12M.
12. Gazzaruso, C., Giordanetti, S., De Amici, E., Bertone, G., Falcone, C., Geroldi, D., Fratino, P., Solerte, S. B. & Garzaniti, A. (2004) Relationship between erectile dysfunction and silent myocardial ischemia in apparently uncomplicated type 2 diabetic patients. Circulation 110, 22-26.
13. Goldstein, I., Young, J. M., Fischer, J., Bangerter, K., Segerson, T. & Taylor, T. (2003) Vardenafil, a new phosphodiesterase type 5 inhibitor, in the treatment of erectile dysfunction in men with diabetes: a multicenter double-blind placebo-controlled fixed-dose study. Diabetes Care 26, 777-783.
14. Grimm, R. H., Jr, Grandits, G. A., Prineas, R. J., McDonald, R. H., Lewis, C. E., Flack, J. M., Yunis, C., Svendsen, K., Liebson, P. R. & Elmer, P. J. (1997) Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women. Treatment of mild hypertension study (TOMHS). Hypertension 29, 8-14.
15. Hakim, L. S. & Goldstein, I. (1996) Diabetic sexual dysfunction. Endocrinology and Metabolism Clinics of North America 25, 379-400.
16. Jackson, G. (1999) Erectile dysfunction and cardiovascular disease. Int J Clin Pract 53, 363-368.
17. Kirby, M., Jackson, G. & Simonsen, U. (2005) Endothelial dysfunction links erectile dysfunction to heart disease. Int J Clin Pract 59, 225-229.
18. Klein, R., Klein, B. E., Lee, K. E., Moss, S. E. & Cruickshanks, K. J. (1996) Prevalence of self-reported erectile dysfunction in people with long-term IDDM. Diabetes Care 19, 135-141.
19. Kloner, R. (2007) Erectile dysfunction and hypertension. International Journal of Impotence Research 19, 296-302.
20. Ko, D. T., Hebert, P. R., Coffey, C. S., Sedrakyan, A., Curtis, J. P. & Krumholz, H. M. (2002) Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction. JAMA 288, 351-357.
21. Kong, A. P., So, W. Y., Szeto, C. C., Chan, N. N., Luk, A., Ma, R. C. et al. (2006) Assessment of glomerular filtration rate in addition to albuminuria is important in managing type II diabetes. Kidney International 69, 383-387.
22. Lester, E., Grant, A. J. & Woodroffe, F. J. (1980) Impotence in diabetic and non-diabetic hospital outpatients. Br Med J 281, 354-355.
23. Ma, Y. C., Zuo, L., Chen, J. H., Luo, Q., Yu, X. Q., Li, Y. et al. (2006) Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. Journal of the American Society of Nephrology 17, 2937-2944.
24. Maas, R., Schwedhelm, E., Albsmeier, J. & Boger, R. H. (2002) The pathophysiology of erectile dysfunction related to endothelial dysfunction and mediators of vascular function. Vasc Med 7, 213-225.
25. Marwick, C. (1999) Survey says patients expect little physician help on sex. JAMA 281, 2173-2174.
26. McCulloch, D. K., Campbell, I. W., Wu, F. C., Prescott, R. J. & Clarke, B. F. (1980) The prevalence of diabetic impotence. Diabetologia 18, 279-283.
27. Mota, M., Lichiardopol, C., Mota, E., Panus, C. & Panus, A. (2003) Erectile dysfunction in diabetes mellitus. Romanian Journal of Internal Medicine 41, 163-177.
28. NIH (1993) NIH consensus conference. Impotence. NIH consensus development panel on impotence. JAMA 270, 83-90.
29. Pegge, N. C., Twomey, A. M., Vaughton, K., Gravenor, M. B., Ramsey, M. W. & Price, D. E. (2006) The role of endothelial dysfunction in the pathophysiology of erectile dysfunction in diabetes and in determining response to treatment. Diabetic Medicine 23, 873-878.
30. Piwernetz, K., Home, P. D., Snorgaard, O., Antsiferov, M., Staehr-Johansen, K. & Krans, M. (1993) Monitoring the targets of the St. Vincent declaration and the implementation of quality management in diabetes care: The Diabcare initiative. The Diabcare monitoring group of the St. Vincent declaration steering committee. Diabetic Medicine 10, 371-377.
31. Proceedings of the 1st Latin American erectile dysfunction consensus. August 28-31, 2002. Costa do Sauipe, Brazil. (2003) International Journal of Impotence Research 15(Suppl 7), S1-S45.
32. Rendell, M. S., Rajfer, J., Wicker, P. A. & Smith, M. D. (1999) Sildenafil for treatment of erectile controlled trial. Sildenafil diabetes study group. JAMA 281, 421-426.
33. Rosen, R. C., Cappelleri, J. C., Smith, M. D., Lipsky, J. & Pena, B. M. (1999) Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. International Journal of Impotence Research 11, 319-326.
34. Rubin, A. & Babbott, D. (1958) Impotence and diabetes mellitus. J Am Med Assoc 168, 498-500.
35. Saenz de Tejada, I., Anglin, G., Knight, J. R. & Emmick, J. T. (2002) Effects of tadalafil on erectile dysfunction in men with diabetes. Diabetes Care 25, 2159-2164.
36. Sasaki, H., Yamasaki, H., Ogawa, K., Nanjo, K., Kawamori, R., Iwamoto, Y., Katayama, S. & Shirai, M. (2005) Prevalence and risk factors for erectile dysfunction in Japanese diabetics. Diabetes Research and Clinical Practice 70, 81-89.
37. Siu, S. C., Lo, S. K., Wong, K. W., Ip, K. M. & Wong, Y. S. (2001) Prevalence of and risk factors for erectile dysfunction in Hong Kong diabetic patients. Diabetic Medicine 18, 732-738.
38. Solomon, H., Man, J., Wierzbicki, A. S., O'Brien, T. & Jackson, G. (2003) Erectile dysfunction: cardiovascular risk and the role of the cardiologist. Int J Clin Pract 57, 96-99.
39. Stuckey, B. G., Walsh, J. P., Ching, H. L., Stuckey, A. W., Palmer, N. R., Thompson, P. L. & Watts, G. F. (2007) Erectile dysfunction predicts generalised cardiovascular disease: evidence from a case-control study. Atherosclerosis 194, 458-464.
40. Tong, P. C., Lee, K. F., So, W. Y., Ng, M. H., Chan, W. B., Lo, M. K., Chan, N. N. & Chan, J. C. (2004) White blood cell count is associated with macro- and microvascular complications in chinese patients with type 2 diabetes. Diabetes Care 27, 216-222.
41. World Health Organization, International Association for the Study of Obesity, International Obesity Task Force. (2000) The Asia-Pacific Perspecitve: Redefining obesity and its treatment. Health Communications Australia, Sydney, Australia.
42. Yamasaki, H., Ogawa, K., Sasaki, H., Nakao, T., Wakasaki, H., Matsumoto, E. et al. (2004) Prevalence and risk factors of erectile dysfunction in Japanese men with type 2 diabetes. Diabetes Research and Clinical Practice 66(Suppl 1), S173-S177.
43. Yang, X. L., So, W. Y., Kong, A. P., Clarke, P., Ho, C. S., Lam, C. W. et al. (2006) End-stage renal disease risk equations for Hong Kong Chinese patients with type 2 diabetes: Hong Kong diabetes registry. Diabetologia 49, 2299-2308.
44. Zheng, H., Fan, W., Li, G. & Tam, T. (2006) Predictors for erectile dysfunction among diabetics. Diabetes Research and Clinical Practice 71, 313-319.